Home » Topics » BioWorld Science

BioWorld Science
RSS

Aro's Centyrin-targeted siRNA conjugates show potential for Pompe disease

May 12, 2022

CRB-601 shows promising antitumor activity alone or in combination with immunotherapy

May 12, 2022

Myrtelle launches new research program for Pelizaeus-Merzbacher disease

May 12, 2022

GT-02329 shows promise in in vitro and in vivo Gaucher disease models

May 12, 2022

Targeting bromodomain in Brg-1 unveiled as a promising approach for uveal melanoma

May 12, 2022

PEGylation of bispecific antibody IGT-427 improves potential for treating retinal diseases

May 12, 2022

New PROTACs presented by C4 Therapeutics

May 12, 2022

Gilead Sciences presents new compounds for viral infections

May 12, 2022

Rheos Medicines identifies new MALT1 inhibitors

May 12, 2022

Sichuan Haisco Pharmaceutical divulges new JAK inhibitors

May 12, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...